Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite promising immunotherapy, response rates remain suboptimal. Tumour-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback